A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.
about
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysisLarval zebrafish model for FDA-approved drug repositioning for tobacco dependence treatmentEffects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, studySelective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neuronsCompromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline.Drug-drug interactions between warfarin and psychotropics: updated review of the literature.Pharmacogenetic Optimization of Smoking Cessation Treatment.The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trialEffects of varenicline on abstinence and smoking reward following a programmed lapse.Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individualsVarenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons.Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study.Pharmacokinetic-pharmacodynamic modeling of the effect of varenicline on nicotine craving in adult smokers.Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders.Role of nicotine receptor partial agonists in tobacco cessation.Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease.Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use DisordersAcute activation, desensitization and smoldering activation of human acetylcholine receptors.Renal Drug Transporters and Drug Interactions.The effect of smoking cessation pharmacotherapies on pancreatic beta cell functionMeasures and predictors of varenicline adherence in the treatment of nicotine dependence.Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.Selective and regulated trapping of nicotinic receptor weak base ligands and relevance to smoking cessation.Evaluation of Prolonged Exposure to Varenicline in Adult Rats: Hematological, Biochemical and Anatomopathological Studies.Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles.Phase II crossover trial of varenicline in mild-to-moderate Alzheimer's disease.Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study.Fatality following a suicidal overdose with varenicline.Immediate release tablet formulation of varenicline salicylate and comparative pharmacokinetic study in human volunteers
P2860
Q24602146-EF6C1B99-4D58-4546-99DB-102B649B00C6Q28541293-9BCFC842-D635-4EAF-8CC7-5736B2151494Q30443702-7B3DDD6C-E701-457C-8AA1-CEDBEBE25BEDQ30467200-6BA036EF-AF75-46B8-99B4-8C26A86871E2Q33684431-C1F09B34-C939-4176-81B1-C42C977AC7E1Q34432843-608D5D0F-4DF2-46F3-AF70-8A5DECE3D9E2Q34542169-5426B421-F62F-46DE-84A2-AB26B456D242Q35885499-0574FF98-2D5F-442E-9107-15CC071DE70CQ36471957-800D08C7-4C42-4A37-9979-B087FB6B7AD4Q36594551-45EF53BA-55A3-40F7-9632-E1B3E3AFDCD9Q36687594-7F7CFCB6-3BB1-492D-8753-8C8E384C13A4Q36798993-88A2A47F-C750-44F9-BEA5-C215FEAFD4CAQ36801536-4604A955-3162-4E75-8872-244A7865DD7CQ36936258-9A71A14C-80FA-4FFA-83C5-0B0C4BD59F70Q37589870-2E47E7E8-EAD6-4B62-829D-6E3AD75C14DAQ37642452-E6CE41F1-E8CD-4142-9AA8-1FF148B9A12AQ38287050-EF392159-7E08-47C9-BF6A-B5FDD8D667FFQ38758931-9EA617C8-76B1-41C8-95F1-BB738A557034Q38815352-FB91F9F1-1977-434E-8F11-82E514753F23Q38950639-A81B42EA-15CC-4B38-9F96-E008ECB63DFCQ39061997-E721B371-BE4E-4C4D-BF7A-86398BE5EDE9Q39140289-48572BA9-6AC5-4D69-BFA8-142E03D21AA8Q39283223-19AE0D49-DE8A-4913-9087-53BD42762909Q40114814-41A0A70B-80D1-4A76-A3D9-159EF7DBA7B4Q40587312-DFC8F231-B4DF-469A-9C8C-AB48E0F2126FQ41283764-9CEA817D-902B-4C69-9030-4BA5C0F2F04AQ46301289-2C217E30-0B0A-4727-9BC7-CFCEEE411CD8Q46803842-7992F1EE-29F1-4D75-8BA7-24DBC5A466A9Q48398801-20BD92E0-EBE2-4E02-AF6C-E78EABA303ABQ48444993-3F742C8C-E414-45E1-A510-C4A56E100D23Q48666297-6BA501F4-F0AE-4FC1-BB8C-DCDC858BB4A6Q57816556-7199AC04-D642-4F4C-8D5B-1A2928CE033D
P2860
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of the clinical pharm ...... nicline for smoking cessation.
@en
A review of the clinical pharm ...... nicline for smoking cessation.
@nl
type
label
A review of the clinical pharm ...... nicline for smoking cessation.
@en
A review of the clinical pharm ...... nicline for smoking cessation.
@nl
prefLabel
A review of the clinical pharm ...... nicline for smoking cessation.
@en
A review of the clinical pharm ...... nicline for smoking cessation.
@nl
P2093
P2860
P1476
A review of the clinical pharm ...... nicline for smoking cessation.
@en
P2093
Aaron H Burstein
Hans Rollema
Hélène M Faessel
Kathryn E Williams
Patanjali Ravva
R Scott Obach
P2860
P304
P356
10.2165/11537850-000000000-00000
P577
2010-12-01T00:00:00Z
P6179
1034155428